activesellsec_filings

CRM 10-Q report for 2025-07-31

This play documents Salesforce, Inc.’s Form 10‑Q for the quarter ended July 31, 2025. The filing includes condensed consolidated financial statements for the three- and six-month periods, balance sheet and cash flow detail, and an index to MD&A, market risk and controls. Use this filing to verify reported results, capital structure and disclosures; it does not by itself provide a definitive trading catalyst.

Confidence
60 / 100
Assets
1
Authors
1
Outcome
open

Linked assets

Primary ticker: CRM (Salesforce, Inc., New York Stock Exchange). The filing reports key line items (revenues, net income, cash and cash equivalents, unearned revenue, debt and treasury stock) as of July 31, 2025.

CRMSalesforce, Inc.sellopen

CRM is the equity ticker for Salesforce, Inc., a Technology sector company in the Software - Application industry.

Confidence: 60 / 100Start: $244.01Latest: $172.42Return: 29.34%

This play references Salesforce, Inc.’s Form 10‑Q for the quarter ended July 31, 2025, which contains unaudited condensed consolidated financial statements and related disclosures. Key reported items include: cash and cash equivalents $10,365 million; total assets $97,573 million; total liabilities $36,245 million; total stockholders’ equity $61,328 million; three‑month revenue $10,236 million and net income $1,887 million; six‑month revenue $20,065 million and net income $3,428 million. The filing also lists approximately 952 million shares outstanding as of August 28, 2025 and provides an index to MD&A, market risk and risk factors. The document is a primary-source SEC filing and should be used to verify reported results and capital‑structure items; on its own it is not a definitive directional catalyst.

Source proof

Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review

Source: Salesforce, Inc. Form 10‑Q (Quarterly report) for the period ended July 31, 2025. Document contains unaudited condensed consolidated balance sheets, statements of operations, comprehensive income, stockholders’ equity and cash flows, plus notes and table of contents referencing MD&A and risk factors.

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Prepared from the company’s filed Form 10‑Q. Summary derived from one author/curation source in our system.

Unlock full thesis monitoring

Recommended strategy: sell (play status: active, outcome: open). Use the filing to validate reported metrics and capital‑structure details; combine with other research before trading.